GMO Pepabo, Inc. Logo

GMO Pepabo, Inc.

3633.T

(0.5)
Stock Price

1.360,00 JPY

5.76% ROA

31.13% ROE

12.11x PER

Market Cap.

7.129.222.947,00 JPY

38.06% DER

4.07% Yield

5.48% NPM

GMO Pepabo, Inc. Stock Analysis

GMO Pepabo, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

GMO Pepabo, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock maintains a fair debt to equity ratio (99%), indicating a reasonable balance between the money it owes and the ownership it possesses.

2 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (26.058) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

3 ROE

The stock's ROE indicates a negative return (-24.35%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-5.52%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (32.08x) suggests it's overvalued, potentially making it an expensive investment.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

GMO Pepabo, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

GMO Pepabo, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

GMO Pepabo, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

GMO Pepabo, Inc. Revenue
Year Revenue Growth
2008 2.214.420.000
2009 2.721.215.000 18.62%
2010 3.100.624.000 12.24%
2011 3.418.742.000 9.31%
2012 3.809.427.000 10.26%
2013 4.165.109.000 8.54%
2014 4.533.716.000 8.13%
2015 5.697.805.000 20.43%
2016 6.890.214.000 17.31%
2017 7.365.338.000 6.45%
2018 8.200.997.000 10.19%
2019 8.943.032.000 8.3%
2020 11.014.036.000 18.8%
2021 11.879.940.000 7.29%
2022 10.531.259.000 -12.81%
2023 10.806.964.000 2.55%
2023 10.903.608.000 0.89%
2024 10.873.208.000 -0.28%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

GMO Pepabo, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 19.104.000 100%
2018 24.591.000 22.31%
2019 27.030.000 9.02%
2020 33.012.000 18.12%
2021 30.445.000 -8.43%
2022 29.611.000 -2.82%
2023 0 0%
2023 29.144.000 100%
2024 18.200.000 -60.13%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

GMO Pepabo, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 1.205.000.000 100%
2013 1.333.000.000 9.6%
2014 1.407.000.000 5.26%
2015 1.896.095.000 25.79%
2016 2.378.434.000 20.28%
2017 0 0%
2018 0 0%
2019 3.890.739.000 100%
2020 4.660.711.000 16.52%
2021 4.939.887.000 5.65%
2022 4.260.452.000 -15.95%
2023 0 0%
2023 5.355.948.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

GMO Pepabo, Inc. EBITDA
Year EBITDA Growth
2008 521.818.000
2009 639.544.000 18.41%
2010 756.215.000 15.43%
2011 741.916.000 -1.93%
2012 794.527.000 6.62%
2013 928.760.000 14.45%
2014 932.652.000 0.42%
2015 -198.108.000 570.78%
2016 222.534.000 189.02%
2017 355.889.000 37.47%
2018 711.630.000 49.99%
2019 1.102.107.000 35.43%
2020 892.817.000 -23.44%
2021 1.223.533.000 27.03%
2022 1.111.377.000 -10.09%
2023 978.952.000 -13.53%
2023 113.892.000 -759.54%
2024 1.571.784.000 92.75%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

GMO Pepabo, Inc. Gross Profit
Year Gross Profit Growth
2008 1.254.469.000
2009 1.518.933.000 17.41%
2010 1.577.026.000 3.68%
2011 1.820.566.000 13.38%
2012 2.059.299.000 11.59%
2013 2.251.898.000 8.55%
2014 2.412.430.000 6.65%
2015 3.069.758.000 21.41%
2016 3.911.654.000 21.52%
2017 4.436.068.000 11.82%
2018 4.908.138.000 9.62%
2019 5.251.288.000 6.53%
2020 6.481.533.000 18.98%
2021 6.732.634.000 3.73%
2022 6.076.367.000 -10.8%
2023 5.859.444.000 -3.7%
2023 5.931.104.000 1.21%
2024 5.717.072.000 -3.74%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

GMO Pepabo, Inc. Net Profit
Year Net Profit Growth
2008 238.599.000
2009 339.453.000 29.71%
2010 350.722.000 3.21%
2011 411.585.000 14.79%
2012 396.822.000 -3.72%
2013 408.279.000 2.81%
2014 410.443.000 0.53%
2015 -797.754.000 151.45%
2016 153.417.000 619.99%
2017 119.820.000 -28.04%
2018 467.075.000 74.35%
2019 542.746.000 13.94%
2020 829.917.000 34.6%
2021 715.415.000 -16%
2022 510.092.000 -40.25%
2023 671.984.000 24.09%
2023 -628.787.000 206.87%
2024 681.452.000 192.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

GMO Pepabo, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 47
2009 64 28.13%
2010 66 3.03%
2011 78 14.29%
2012 75 -4.05%
2013 77 2.63%
2014 76 -1.33%
2015 -150 150.34%
2016 16 1031.25%
2017 23 27.27%
2018 89 75%
2019 104 15.38%
2020 159 34.59%
2021 135 -17.78%
2022 96 -40.63%
2023 0 0%
2023 -119 100%
2024 129 192.25%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

GMO Pepabo, Inc. Free Cashflow
Year Free Cashflow Growth
2008 433.493.000
2009 524.328.000 17.32%
2010 236.027.000 -122.15%
2011 434.879.000 45.73%
2012 384.513.000 -13.1%
2013 491.567.000 21.78%
2014 849.050.000 42.1%
2015 -834.675.000 201.72%
2016 516.624.000 261.56%
2017 403.378.000 -28.07%
2018 404.085.000 0.17%
2019 331.098.000 -22.04%
2020 892.507.000 62.9%
2021 338.838.000 -163.4%
2022 -708.881.000 147.8%
2023 1.496.478.000 147.37%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

GMO Pepabo, Inc. Operating Cashflow
Year Operating Cashflow Growth
2008 494.659.000
2009 620.572.000 20.29%
2010 427.791.000 -45.06%
2011 570.433.000 25.01%
2012 590.197.000 3.35%
2013 689.269.000 14.37%
2014 1.033.396.000 33.3%
2015 -503.160.000 305.38%
2016 705.083.000 171.36%
2017 639.947.000 -10.18%
2018 674.659.000 5.15%
2019 698.304.000 3.39%
2020 1.253.362.000 44.29%
2021 669.077.000 -87.33%
2022 -213.395.000 413.54%
2023 1.897.501.000 111.25%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

GMO Pepabo, Inc. Capital Expenditure
Year Capital Expenditure Growth
2008 61.166.000
2009 96.244.000 36.45%
2010 191.764.000 49.81%
2011 135.554.000 -41.47%
2012 205.684.000 34.1%
2013 197.702.000 -4.04%
2014 184.346.000 -7.25%
2015 331.515.000 44.39%
2016 188.459.000 -75.91%
2017 236.569.000 20.34%
2018 270.574.000 12.57%
2019 367.206.000 26.32%
2020 360.855.000 -1.76%
2021 330.239.000 -9.27%
2022 495.486.000 33.35%
2023 401.023.000 -23.56%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

GMO Pepabo, Inc. Equity
Year Equity Growth
2008 707.702.000
2009 943.623.000 25%
2010 1.150.630.000 17.99%
2011 1.390.021.000 17.22%
2012 1.615.818.000 13.97%
2013 1.894.079.000 14.69%
2014 2.108.204.000 10.16%
2015 1.012.350.000 -108.25%
2016 1.184.970.000 14.57%
2017 1.223.048.000 3.11%
2018 1.706.868.000 28.35%
2019 1.769.891.000 3.56%
2020 2.544.403.000 30.44%
2021 2.953.236.000 13.84%
2022 2.689.051.000 -9.82%
2023 1.710.418.000 -57.22%
2023 1.811.168.000 5.56%
2024 2.101.850.000 13.83%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

GMO Pepabo, Inc. Assets
Year Assets Growth
2008 1.734.081.000
2009 2.269.981.000 23.61%
2010 2.504.579.000 9.37%
2011 3.001.443.000 16.55%
2012 3.375.662.000 11.09%
2013 3.791.896.000 10.98%
2014 4.414.982.000 14.11%
2015 4.062.550.000 -8.68%
2016 4.770.075.000 14.83%
2017 5.376.958.000 11.29%
2018 6.077.707.000 11.53%
2019 6.371.807.000 4.62%
2020 8.211.659.000 22.41%
2021 8.870.222.000 7.42%
2022 11.435.946.000 22.44%
2023 10.695.633.000 -6.92%
2023 10.947.693.000 2.3%
2024 10.864.659.000 -0.76%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

GMO Pepabo, Inc. Liabilities
Year Liabilities Growth
2008 1.026.379.000
2009 1.326.358.000 22.62%
2010 1.353.949.000 2.04%
2011 1.611.422.000 15.98%
2012 1.759.844.000 8.43%
2013 1.897.817.000 7.27%
2014 2.306.778.000 17.73%
2015 3.050.200.000 24.37%
2016 3.585.105.000 14.92%
2017 4.153.910.000 13.69%
2018 4.370.839.000 4.96%
2019 4.601.916.000 5.02%
2020 5.667.256.000 18.8%
2021 5.916.986.000 4.22%
2022 8.746.895.000 32.35%
2023 8.985.215.000 2.65%
2023 9.136.523.000 1.66%
2024 8.762.807.000 -4.26%

GMO Pepabo, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2036.22
Net Income per Share
111.58
Price to Earning Ratio
12.11x
Price To Sales Ratio
0.66x
POCF Ratio
9.94
PFCF Ratio
9.94
Price to Book Ratio
3.39
EV to Sales
0.35
EV Over EBITDA
2.75
EV to Operating CashFlow
5.24
EV to FreeCashFlow
5.24
Earnings Yield
0.08
FreeCashFlow Yield
0.1
Market Cap
7,13 Bil.
Enterprise Value
3,76 Bil.
Graham Number
999.98
Graham NetNet
-89.69

Income Statement Metrics

Net Income per Share
111.58
Income Quality
-1.39
ROE
0.31
Return On Assets
0.05
Return On Capital Employed
0.32
Net Income per EBT
0.7
EBT Per Ebit
0.86
Ebit per Revenue
0.09
Effective Tax Rate
0.3

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.53
Operating Profit Margin
0.09
Pretax Profit Margin
0.08
Net Profit Margin
0.05

Dividends

Dividend Yield
0.04
Dividend Yield %
4.07
Payout Ratio
0
Dividend Per Share
55

Operating Metrics

Operating Cashflow per Share
135.94
Free CashFlow per Share
135.94
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.24
Return on Tangible Assets
0.06
Days Sales Outstanding
84.26
Days Payables Outstanding
18.62
Days of Inventory on Hand
0.71
Receivables Turnover
4.33
Payables Turnover
19.61
Inventory Turnover
514.12
Capex per Share
0

Balance Sheet

Cash per Share
1.217,42
Book Value per Share
398,30
Tangible Book Value per Share
277.61
Shareholders Equity per Share
398.3
Interest Debt per Share
153.85
Debt to Equity
0.38
Debt to Assets
0.07
Net Debt to EBITDA
-2.47
Current Ratio
1.11
Tangible Asset Value
1,46 Bil.
Net Current Asset Value
-0,09 Bil.
Invested Capital
2342014000
Working Capital
0,89 Bil.
Intangibles to Total Assets
0.06
Average Receivables
2,65 Bil.
Average Payables
0,28 Bil.
Average Inventory
8515000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

GMO Pepabo, Inc. Dividends
Year Dividends Growth
2010 130
2011 130 0%
2012 135 3.7%
2013 135 0%
2014 135 0%
2015 135 0%
2016 30 -350%
2017 25 -20%
2018 10 -150%
2019 65 84.62%
2020 53 -25%
2021 81 35.8%
2022 50 -62%
2023 55 9.09%
2024 0 0%

GMO Pepabo, Inc. Profile

About GMO Pepabo, Inc.

GMO Pepabo, Inc. provides consumer-targeted Internet services in Japan. It operates through four segments: Hosting, Ecommerce Support, Customer to Customer (C2C), and Community. The Hosting segment offers consumer domain registration and web hosting services. The Ecommerce Support segment provides ecommerce platform solutions. The C2C segment offers marketplace for handmade products. The Community segment facilitates communication among Internet users through blogging. The company was formerly known as Paperboy&Co., Inc. and changed its name to GMO Pepabo, Inc. in March 2014. The company was founded in 2003 and is headquartered in Tokyo, Japan. GMO Pepabo, Inc operates as a subsidiary of GMO Internet, Inc

CEO
Mr. Masatoshi Kumagai
Employee
359
Address
Cerulean Tower
Tokyo, 150-8512

GMO Pepabo, Inc. Executives & BODs

GMO Pepabo, Inc. Executives & BODs
# Name Age
1 Ms. Maho Nogami
Chief Integrity Officer, GM of Business Administration Department & Director
70
2 Mr. Hayato Hoshi
Executive Vice President & Director
70
3 Yukio Sugino
Executive Officer
70
4 Mr. Kentaro Sato
President & Representative Director
70
5 Mr. Masaki Arai
Executive Officer & GM of Minne Business Department
70
6 Hideaki Terai
Executive Officer
70
7 Mr. Hironori Nagashii
Executive Officer & Fukuoka Branch President
70
8 Mr. Masatoshi Kumagai
Executive Chairman
70
9 Mr. Yoshito Igashima
MD, Chief Financial Officer, GM of HR, GM of Corporate Strategy Department & Director
70
10 Mr. Kentaro Kuribayashi
Chief Technology Officer, GM of Business Development Department & Director
70

GMO Pepabo, Inc. Competitors

I'LL inc. Logo
I'LL inc.

3854.T

(3.5)
Enigmo Inc. Logo
Enigmo Inc.

3665.T

(1.8)
Dear Life Co.,Ltd. Logo
Dear Life Co.,Ltd.

3245.T

(2.8)